Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2008

View Archived Issues

Clinical data on elotuzumab in multiple myeloma emerging

Antineoplastons induce responses in anaplastic astrocytoma patients

Synergy successfully completes phase I trial of SP-304 in healthy subjects

ITI presents development update of ITI-111 for acute repetitive seizure in epilepsy

Novel agents for treating HCV infection jointly disclosed by Array and InterMune

Novavax reports preclinical results from study of RSV vaccine in mice

Wyeth initiates phase I study of Ablynx Nanobody targeting TNF-alpha

Cytos initiates phase IIb clinical study of CYT003-QbG10 for allergy and asthma

Futura reports results from phase I study of PET-500 for premature ejaculation

Neogenix to initiate clinical trial of monoclonal antibodies for colorectal and pancreatic cancer

Javelin reports results from phase III efficacy study of Dyloject in postsurgical pain

Clinical results disclosed for a novel inhibitor of sodium and calcium channels in epilepsy

Arana commences international phase II trial of ART-621 in rheumatoid arthritis

Calcineurin inhibition can guide dosing of voclosporin in plaque psoriasis patients

InterMune to report triple combination ITMN-191 study results in January

CBP-501 enters phase II trials for malignant pleural mesothelioma

Halozyme starts dosing in phase I trial of bisphosphonate plus rHuPH20 enzyme

KAI-1678 enters phase IIa trials for the treatment of pain

Palatin and AstraZeneca extend research collaboration and license agreement

Alexza reports positive results from phase III clinical trial of AZ-004 in bipolar disorder

Almirall reports positive results from phase IIa study of LAS-100977 in asthma

Novel Pan-PI3 kinase inhibitor identified for leukemia and myeloma

Recent patents describe new treatment options for endocrine-associated disorders

Recent patents disclose new treatments for obesity

FDA approves Lusedra for sedation in diagnostic or therapeutic procedures

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...